Increase in urolithiasis prevalence due to vitamins C and D supplementation during the COVID-19 pandemic.

Karam, Aya; Mjaess, Georges; Younes, Hadi; Aoun, Fouad

Karam, Aya; Mjaess, Georges; Younes, Hadi; Aoun, Fouad.

Karam A; Hotel-Dieu de France, Saint Joseph University, Beirut 1004, Lebanon.
Mjaess G; Hotel-Dieu de France, Saint Joseph University, Beirut 1004, Lebanon.
Younes H; Hotel-Dieu de France, Saint Joseph University, Beirut 1004, Lebanon.
Aoun F; Hotel-Dieu de France, Saint Joseph University, Beirut 1004, Lebanon.

J Public Health (Oxf) ; 44(4): e625-e626, 2022 Dec 01.

Article in English | MEDLINE | ID: covidwho-1393320

Subject(s)

COVID-19; Urolithiasis; Humans; Ascorbic Acid/therapeutic use; Dietary Supplements; Pandemics; Prevalence; Vitamins/therapeutic use; Vitamin D/therapeutic use

Keywords

COVID-19; kidney stone; urolithiasis; vitamin C; vitamin D

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Urolithiasis / COVID-19 Type of study: Observational study Topics: Traditional medicine Limits: Humans Language: English Journal: J Public Health (Oxf) Year: 2022 Document Type: Article Affiliation country: Pubmed

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google